UNSPSC 51286301: Picloxydine

This classification denotes a topical anti-infective agent with the molecular formula C20H24Cl2N10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4YC2PY3AEU, chemically known as 1,1-(1,4-piperazinediylbis(imidocarbonyl))bis(3-(p-chlorophenyl)guanidine) but more generally known as picloxydine, which bears US NIH Compound Identifier 5748610. European Medicines Agency schedules Picloxydine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09813MIG.

UNSPSC 51286301 Picloxydine (Commodity) does not map cleanly to the state and local procurement activity recorded under this code. The four most recent opportunities tagged to this commodity involve naloxone and drug deactivation systems, direct-to-manufacturer pharmaceutical prescriptions, medical and first aid supplies for fire departments, and generic pharmaceuticals and OTC products through cooperative purchasing—none of which center on picloxydine as an active ingredient or procurement focus. The Commodity code name and the actual solicited work diverge significantly, and the source provides no evidence of state or local governments actively buying picloxydine itself in recent postings.

The single opportunity closest to the code's nominal scope is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, which solicits 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding with a response deadline of July 26, 2023, and quarterly deliveries to the Seminole County Community Health Building in Sanford. The remaining three opportunities—Texas HHS's RFI HHS0017013 for direct-to-manufacturer pharmacy programs (April 2026), the City of Tampa's IFB 26P00145 for medical and first aid supplies for the Fire Department ($700,000 estimated value, March 2026 due date, with a 5 percent SLBE bid discount not to exceed $10,000), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic pharmaceuticals and OTC products (due March 26, 2026)—address pharmaceutical procurement broadly but do not isolate picloxydine or its therapeutic class. State and local purchasing activity under this Commodity code shows minimal recent specificity to picloxydine itself; buyers should confirm whether the underlying requirement has shifted to broader pharmaceutical or antimicrobial categories before committing pursuit resources.